T1	Reference 7 13	survey
T2	Concept 38 43	81.1%
T3	Concept 51 58	parents
R1	in-context Arg1:T2 Arg2:T3	
T4	Action 64 80	paying attention
T5	Concept 88 96	COVID-19
T6	Concept 97 105	epidemic
R2	is-a Arg1:T5 Arg2:T6	
T7	Concept 131 134	CKD
T8	Concept 148 153	4.32%
T9	Action 154 161	planned
T10	Action 165 171	adjust
T11	Concept 187 193	dosage
T12	Concept 176 186	medication
R3	in-context Arg1:T8 Arg2:T3	
R4	subject Arg1:T4 Arg2:T2	
R5	target Arg1:T4 Arg2:T5	
R6	target Arg1:T4 Arg2:T7	
R7	subject Arg1:T9 Arg2:T8	
R8	target Arg1:T9 Arg2:T10	
R9	has-property Arg1:T11 Arg2:T12	
R10	target Arg1:T10 Arg2:T11	
T13	Action 194 199	based
T14	Concept 209 217	previous
T15	Concept 218 225	medical
T16	Concept 226 235	knowledge
T17	Concept 240 250	experience
R11	has-property Arg1:T16 Arg2:T15	
R12	has-property Arg1:T16 Arg2:T14	
R13	in-context Arg1:T10 Arg2:T13	
R14	target Arg1:T13 Arg2:T16	
R15	target Arg1:T13 Arg2:T17	
R16	in-context Arg1:T4 Arg2:T1	
R17	in-context Arg1:T9 Arg2:T1	
T18	Action 289 297	severity
T19	Concept 301 316	lymphocytopenia
T20	Action 323 331	indicate
A1	Uncertain T20
T21	Action 336 344	severity
T22	Concept 348 356	COVID-19
R18	target Arg1:T18 Arg2:T19	
R19	target Arg1:T20 Arg2:T21	
R20	target Arg1:T21 Arg2:T22	
R21	subject Arg1:T20 Arg2:T18	
T23	Action 368 378	assumption
T24	Concept 382 392	SARS-CoV-2
T25	Action 405 411	attack
T26	Action 416 423	destroy
A3	Uncertain T26
A2	Uncertain T25
T27	Concept 439 449	targetedly
T28	Concept 428 438	lymphocyte
R22	in-context Arg1:T20 Arg2:T23	
R23	target Arg1:T23 Arg2:T25	
R24	target Arg1:T23 Arg2:T26	
R25	subject Arg1:T25 Arg2:T24	
R26	subject Arg1:T26 Arg2:T24	
R27	has-property Arg1:T28 Arg2:T27	
R28	target Arg1:T26 Arg2:T28	
R29	target Arg1:T25 Arg2:T28	
T29	Concept 479 485	44,672
T30	Action 486 495	confirmed
T31	Concept 505 510	cases
T32	Concept 496 504	COVID-19
T33	Concept 514 519	China
R30	in-context Arg1:T29 Arg2:T31	
R31	subject Arg1:T30 Arg2:T29	
R32	target Arg1:T30 Arg2:T32	
R33	in-place Arg1:T30 Arg2:T33	
T34	Concept 526 530	2.1%
T35	Concept 539 548	pediatric
T36	Concept 549 557	patients
R34	has-property Arg1:T36 Arg2:T35	
T37	Concept 559 575	â‰¤19 years of age
R35	entails Arg1:T36 Arg2:T37	
R36	in-context Arg1:T34 Arg2:T29	
R37	is-a Arg1:T34 Arg2:T36	
T38	Concept 592 598	levels
T39	Concept 611 614	ALT
T40	Concept 619 622	AST
T41	Concept 602 610	elevated
T42	Concept 688 696	COVID-19
T43	Concept 706 711	liver
T44	Action 698 705	related
T45	Concept 712 718	injury
R38	has-property Arg1:T45 Arg2:T43	
T46	Concept 726 733	serious
A4	Negated T46
T47	Concept 741 748	initial
T48	Concept 749 754	stage
R39	has-property Arg1:T48 Arg2:T47	
T49	Concept 758 767	infection
R40	in-context Arg1:T49 Arg2:T42	
R41	subject Arg1:T44 Arg2:T45	
R42	target Arg1:T44 Arg2:T42	
R43	has-property Arg1:T38 Arg2:T41	
R44	in-context Arg1:T38 Arg2:T39	
R45	in-context Arg1:T38 Arg2:T40	
T50	Action 641 645	high
A5	Uncertain T50
R46	target Arg1:T50 Arg2:T38	
A6	Negated T50
R47	has-property Arg1:T45 Arg2:T46	
R48	in-time Arg1:T46 Arg2:T47	
R49	entails Arg1:T50 Arg2:T46	
T51	Concept 840 855	lymphocytopenia
T52	Concept 829 839	peripheral
R50	has-property Arg1:T51 Arg2:T52	
T53	Concept 868 875	crucial
A7	Emphasized T53
T54	Concept 887 894	feature
T55	Concept 880 886	common
T56	Concept 899 907	COVID-19
T57	Concept 908 917	infection
R51	in-context Arg1:T57 Arg2:T56	
R52	has-property Arg1:T54 Arg2:T55	
R53	has-property Arg1:T54 Arg2:T53	
R54	is-a Arg1:T51 Arg2:T54	
R55	in-context Arg1:T54 Arg2:T57	
